EDAP TMS S.A. (EDAP)
2.06
-0.01 (-0.48%)
At close: Jan 14, 2025, 3:59 PM
2.02
-1.94%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 2.02 |
| Market Cap | 76.43M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.6 |
| PE Ratio (ttm) | -3.43 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 2.4 |
| Volume | 43,892 |
| Avg. Volume (20D) | 168,113 |
| Open | 2.19 |
| Previous Close | 2.07 |
| Day's Range | 2.00 - 2.19 |
| 52-Week Range | 2.00 - 8.50 |
| Beta | undefined |
About EDAP
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and ma...
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 1, 1997
Employees 307
Stock Exchange NASDAQ
Ticker Symbol EDAP
Website https://www.edap-tms.com
Analyst Forecast
According to 1 analyst ratings, the average rating for EDAP stock is "Buy." The 12-month stock price forecast is $19, which is an increase of 822.33% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
EDAP TMS S.A. is scheduled to release its earnings on Mar 26, 2025,
before market opens.
Analysts project revenue of $21.94M, reflecting a 3.14% YoY growth and earnings per share of -0.12, making a -20.00% decrease YoY.
Analysts project revenue of $21.94M, reflecting a 3.14% YoY growth and earnings per share of -0.12, making a -20.00% decrease YoY.
4 months ago ·
Source
+4.18%
EDAP TMS shares are trading higher after the compa...
Unlock content with
Pro Subscription
